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Effect of VDR gene polymorphisms on osteocalcin secretion regulating genes, have shown influence on either bone
in calcitriol-stimulated human osteoblasts. mass or bone turnover markers [1–4].
Background. The impact of vitamin D receptor (VDR) gene Although the VDR gene polymorphisms have been
polymorphisms in bone metabolism remains controversial. Some
widely studied, their clinical impact remains controver-authors have found a beneficial effect of some VDR gene poly-
sial. Some authors have found a beneficial effect of themorphisms, while others found no differences, or even a lower
bone mass in subjects with the same type of polymorphisms. bb genotype [4], whereas others have found no differ-
The aim of this study was to assess if the VDR gene polymor- ences [5], or even lower bone mass in subjects with the
phisms could have an effect on the calcitriol-stimulated osteo- b allele [6] in the analysis of BsmI polymorphisms, one
calcin in human osteoblasts. of the four VDR gene polymorphisms described to date.Methods. Osteoblasts were obtained from human femoral
These differences could be due to several reasons, suchnecks replaced because of osteoarthritis. Bones were cut into
as differences in the selection criteria, sample size, allelicpieces of 1 to 2 mm and placed in a nylon mesh. After the
migration of osteoblasts, the pieces were collected and cultured heterogeneity, and environmental factors of the different
with different concentrations of calcitriol (108, 109, and 1010 populations studied [7], in addition to the allelic influence
mol/L). After 48 hours of incubation with calcitriol, the osteo- itself. Moreover, in our own population, we have found
calcin secreted into the medium (corrected by either total pro-
a different behavior between genders [8].teins or total DNA content) was measured. The DNA was
The synthesis of the VDR, a transcription factor ofextracted from the osteoblasts, amplified by polymerase chain
osteocalcin, is stimulated by calcitriol [9]. Recent clinicalreaction (PCR), and analyzed for target sequences sites of the
BsmI, ApaI, TaqI, and FokI restriction enzymes. studies have reported that osteocalcin levels might be
Results. The response observed in osteocalcin secretion in influenced by the different VDR gene polymorphisms
the bb or TT genotypes doubled the response observed in the [10–13]. Due to the heterogeneity of the in vivo results,BB or tt genotypes (calcitriol 108 and 109 mol/L). A slight
the aim of our study was to investigate ex vivo if VDRtrend was also observed with the aa genotype. Men showed
gene polymorphisms could have an effect on thehigher levels of osteocalcin secretion than women. Age did not
show any influence in osteocalcin secretion. calcitriol-stimulated osteocalcin secretion in isolated hu-
Conclusion. VDR alleles and gender demonstrated an effect man osteoblasts.
on the osteocalcin secretion. BB or tt genotypes, and also the
“A” allele, showed the lowest calcitriol-stimulated osteocalcin
secretion. METHODS
Primary human osteoblast culture
Osteoblasts were obtained from human femoral necksThe identification of bone metabolism and bone mass–
replaced because of osteoarthritis. The donors (13 men,regulating genes opens new perspectives in the patho-
11 women) had no metabolic disorders and the meangenesis and treatment of metabolic bone disorders. The
age was 69  8 years (range, 50–80 years). The methodsstudy of different gene polymorphisms is a useful tool for
used to obtain the osteoblasts were based on previousassessing the genetic influence on bone metabolism. Vita-
reports by Marie et al [14] and Na`cher et al [15]. Briefly,min D receptor (VDR), estrogen receptor, and collagen
trabecular bone was removed from the femoral necktype I gene polymorphisms, in addition to the TGF1-
and minced into small pieces of about 1 to 2 mm. The
fragments were placed on a nylon mesh and incubated
Key words: VDR genotypes, vitamin D, bone cells. with Dulbecco’s Modified Eagle’s Medium (DMEM),
supplemented with penicillin/streptomycin (100 U/mL 2003 by the International Society of Nephrology
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and 100 g/mL, respectively), nonessential aminoacids Osteocalcin (OC) secretion by the osteoblast
(1x), sodium piruvate (1 mmol/L), and 20% fetal calf serum The osteoblasts were seeded in 96-well plates (Nunc)
(FCS) at 37C in a humidified atmosphere with 5% of CO2. at a density of 15,000 cells/cm2. The cells were incubated
All the reagents used were purchased from Biochrom AG with 100 L of DMEM supplemented with 10% fetal
(Berlin, Germany). After one week, the osteoblasts grew calf serum (FCS) and antibiotics. After three days, the
from the bone pieces to the nylon mesh, surrounding the medium was replaced by DMEM supplemented with
bone. The nylon mesh was then treated with a trypsin/ 0.1% bovine serum albumin (BSA) (Sigma Chemical
EDTA solution (0.25/0.02%) and the osteoblasts were Co.) and incubated for an additional 24 hours. The me-
dium was then replaced by a similar one containing threesubcultured in 75 cm2 flasks (Nunc, Copenhagen, Den-
different concentrations of calcitriol (1010 mol/L, 109mark) with DMEM, supplemented with antibiotics and
mol/L, and 108 mol/L) and incubated for a 48-hour10% FCS to confluency. Cells obtained between the first
period. The supernatants were collected for the measure-and second subcultures were used for the experiments.
ment of osteocalcin (Nichols Institute Diagnostics, SanThe presence of osteoblasts was confirmed by histochem-
Juan Capistrano, CA, USA). Cells were washed twiceical staining for alkaline phosphatase, and by stimulation
with PBS and lysed by freezing and thawing three timeswith calcitriol and measurement of the calcitriol-stimu-
in 100 L of 0.05% Triton X-100. The total proteinlated osteocalcin synthesized.
content and DNA were measured in the lysate. Total
cellular protein was measured by the Bradford methodVDR gene polymorphisms
(BioRad, Richmond, CA, USA) [17]. To determine theDNA was extracted from the osteoblasts following
DNA content, cellular lysate was incubated for 30 min-Miller’s method [16]. Osteoblasts were treated with a
utes at 100C in a steam bath to solubilize the DNA thattrypsin/EDTA solution (0.25/0.02%), washed thoroughly
was measured by a microfluorimetric method [18]. The
with phosphate buffer saline (PBS) (Sigma Chemical Co.,
osteocalcin secretion was corrected using the DNA con-
St. Louis, MO, USA), and then lysed using a solution tent and total cellular protein (Table 1).
containing 10% of sodium dodecyl sulfate and proteinase
K for 24 hours at 37C. Afterwards, 6 mol/L of NaCl Statistical analysis
was added to precipitate DNA with 96% of ethanol. A All data were expressed as mean standard deviation
fragment of 1365 bp of the VDR gene containing BsmI, (SD). Differences in the corrected osteocalcin secretion
ApaI, and TaqI target sites was then amplified by PCR between VDR gene polymorphisms were expressed as
using the following primers: h-VDR1: GCAGAGTGTG fold increase in osteocalcin secreted at the lowest con-
CAGGCGATTCG and h-VDR2: GTGAAGCTCGTG centration of calcitriol (1010 mol/L). It was used at the
TTCC-CCGCAAT in a 30 L reaction volume. PCR lowest concentration because, under no stimulation, the
conditions were 30 seconds at 95C, 15 seconds at 64C, secretion of osteocalcin is almost undetectable [19]. The
and 25 seconds at 72C for 30 cycles. The PCR product Wilcoxon/Mann-Whitney test was used to compare the
was divided into three different aliquots, digested with different VDR polymorphisms.
A multivariate analysis was also performed using osteo-the BsmI, ApaI, and TaqI restriction enzymes (Stratagene,
calcin secretion as dependent variables, and age, gender,La Jolla, CA, USA), and electrophoresed in a 2% aga-
and genotype as independent variables.rose gel. The absence of the target site for the three
endonucleases produced a single band of 1365 bp (alleles
B, A, and T for BsmI, ApaI, and TaqI, respectively). RESULTS
The allele “b” (BsmI) produced two bands of 113 and
The distribution of genotypes found in the primary
1252 bp, the allele “a” (ApaI) 284 and 1081 bp, and the
osteoblast cultures from the 24 different patients studied
allele “t” (TaqI) 208 and 1157 bp. are shown in Table 1. This table also shows a fold increase
The genotyping of the FokI polymorphism was per- over control (1010 mol/L of calcitriol) in osteocalcin
formed at a different PCR amplification using the follow- secretion corrected by proteins at 109 mol/L and 108
ing primers: h-VDR3: GCTCCGAAGGCACTGTGC mol/L of calcitriol. The bb homocygote genotype showed
TCA and h-VDR4: AGAAGATACCACTCACCAAG a significantly higher osteocalcin secretion than the BB
ACC in a 25 L reaction volume. PCR conditions were homocygote genotype with both concentrations of calcitriol
15 seconds at 95C, 15 seconds at 56C, and 40 seconds (109 mol/L and 108 mol/L). The TT homocygote geno-
at 72C for 40 cycles. The PCR product was digested type showed the same pattern but it was only significant
with the FokI restriction enzyme (New England Biolabs, with 109 mol/L of calcitriol. The Bb or Tt heterozygotes
Beverly, MA, USA) and electrophoresed in 2% agarose. showed insignificant increments. The osteocalcin secre-
The presence of the target site produced two fragments tion in the bb or TT genotypes was double that of the
BB or tt genotypes. A similar pattern was seen whenof DNA of 191 and 302 bp (allele “f”).
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Table 1. Fold increase in osteocalcin levels (OC) using 109 mol/L and 108 mol/L concentrations of calcitriol and control
(1010 mol/L of calcitriol)
OC/protein Fold increase Fold increase
Genotypes N (%) control group (109 mol/L/1010 mol/L) (108 mol/L/1010 mol/L)
BB 5 (20.8) 5029 2.51.7 4.01.9
Bb 10 (41.7) 3315 4.71.7 7.53.6
bb 9 (37.5) 3734 5.82.5a 8.34.7a
TT 9 (37.5) 3734 5.82.6a 8.34.9
Tt 9 (37.5) 3516 4.51.7 6.83.1
tt 6 (25.0) 4629 3.02.1 5.64.2
AA 5 (20.8) 4129 4.41.5 7.43.7
Aa 15 (62.5) 4028 4.02.0 6.43.2
aa 4 (16.7) 2816 7.42.8 9.32.8
FF 8 (33.3) 4524 4.21.9 6.84.4
Ff 10 (41.7) 3132 5.72.6 8.24.2
ff 6 (25.0) 4117 3.52.0 5.63.2
Table shows the raw data of osteocalcin corrected by protein in the control group (ng OC/mg protein).
aP  0.05 compared with the BB or tt genotypes
calcitriol, the osteocalcin fold increase was influenced by
the genotype only (  0.522; P  0.009 for BsmI and
  0.461; P  0.014 for TaqI). In a different analysis,
grouping genotypes, the absence of the “A” allele, and
gender correlated with the osteocalcin fold increase with
109 mol/L of calcitriol (  0.440; P  0.018 for aa
genotype;   0.381; P  0.037 for gender).
DISCUSSION
In our study, the distribution of some VDR gene geno-
types was similar to previously published results carried
out in a nonselected population of our region [8] and
also other studies from our country [20, 21]. The mostFig. 1. Fold increase in osteocalcin levels using 108 mol/L and 109
mol/L concentrations of calcitriol and the control (1010 mol/L of common genotype was Bb (42%), followed by bb (37%)
calcitriol) by age and by gender. * P 0.01 men compared with women. and BB (21%).
In the sample studied, the different VDR gene geno-
types and gender showed influence on osteocalcin secre-
tion. The fact that the results have been consistent, eitherosteocalcin secretion was corrected by DNA content in-
expressed as osteocalcin secretion corrected by total pro-stead of proteins. In contrast, no differences were found
teins or by DNA content, excludes in our study anybetween the different ApaI and FokI polymorphisms,
likely influence of apoptosis on bone cells, as it has beenalthough the increase in osteocalcin secretion in the aa
recently suggested [22]. Osteocalcin (bone gla-protein)homocygote genotype with calcitriol 109 mol/L was sig-
is synthesized by osteoblasts and may modify the activitynificant and almost double the other combined geno-
of the cells and their precursors. It marks the turningtypes (AA and Aa) (Table 1).
point between bone formation and resorption and it mayThe age of the donors did not show any significant
regulate mineral maturation [23].influence in the osteocalcin secretion when the sample
Taking into account the known effects of the VDRwas stratified according to the median age (70 years)
gene on the regulation of the osteocalcin gene expres-(Fig. 1). However, osteoblasts in men showed a higher
sion, it is reasonable to hypothesize that, among otherosteocalcin secretion than in women (Fig. 1).
things, different VDR gene polymorphisms may influ-Furthermore, we performed a multiple linear regres-
ence osteocalcin secretion. Our results support this hy-sion analysis using the fold increase over the control of
pothesis, as we found differences in the osteocalcin se-osteocalcin secretion as the dependent variable and age,
creted by human osteoblasts in three out of the fourgender, and genotype (BsmI and TaqI) as independent
VDR gene polymorphisms studied. The presence of thevariables. Only gender correlated with the osteocalcin
fold-increase over the control at 108 mol/L of calcitriol “b” or “T” alleles, and the aa homocygote genotype,
was always associated with a higher osteocalcin secretion(  0.528; P  0.008). However, at 109 mol/L of
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